ANSATIPINE 150 mg, hard capsule 30 capsules
Active ingredients: Rifabutin
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Hard capsule30 capsulesorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ANSATIPINE 150 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 30 gélule(s)
- Marketing authorisation holder
- SERB
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jun 1993
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67699269CIP73360696CIP133400933606961Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIFABUTINEgélule | 150 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.